Charles Schwab’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.7M | Sell |
192,687
-5,973
| -3% | -$321K | ﹤0.01% | 2064 |
|
|
2025
Q4 | $9.63M | Sell |
198,660
-7,781
| -4% | -$303K | ﹤0.01% | 2162 |
|
|
2025
Q3 | $6.32M | Buy |
206,441
+49,306
| +31% | +$1.13M | ﹤0.01% | 2324 |
|
|
2025
Q2 | $3.49M | Buy |
157,135
+3,779
| +2% | +$79.1K | ﹤0.01% | 2482 |
|
|
2025
Q1 | $2.85M | Sell |
153,356
-12,698
| -8% | -$212K | ﹤0.01% | 2503 |
|
|
2024
Q4 | $2.2M | Buy |
166,054
+5,733
| +4% | +$139K | ﹤0.01% | 2649 |
|
|
2024
Q3 | $5.37M | Buy |
160,321
+5,043
| +3% | +$172K | ﹤0.01% | 2339 |
|
|
2024
Q2 | $3.89M | Buy |
155,278
+9,007
| +6% | +$210K | ﹤0.01% | 2456 |
|
|
2024
Q1 | $3.29M | Buy |
146,271
+1,451
| +1% | +$34.4K | ﹤0.01% | 2442 |
|
|
2023
Q4 | $3.1M | Buy |
144,820
+1,809
| +1% | +$31.2K | ﹤0.01% | 2497 |
|
|
2023
Q3 | $2.57M | Buy |
143,011
+3,399
| +2% | +$64.9K | ﹤0.01% | 2523 |
|
|
2023
Q2 | $2.84M | Sell |
139,612
-9,774
| -7% | -$198K | ﹤0.01% | 2444 |
|
|
2023
Q1 | $3.25M | Buy |
149,386
+555
| +0.4% | +$13.5K | ﹤0.01% | 2382 |
|
|
2022
Q4 | $4.61M | Buy |
148,831
+3,343
| +2% | +$94.4K | ﹤0.01% | 2255 |
|
|
2022
Q3 | $3.71M | Buy |
145,488
+3,087
| +2% | +$72.4K | ﹤0.01% | 2378 |
|
|
2022
Q2 | $2.89M | Buy |
142,401
+270
| +0.2% | +$5.98K | ﹤0.01% | 2436 |
|
|
2022
Q1 | $3.52M | Buy |
142,131
+5,819
| +4% | +$176K | ﹤0.01% | 2449 |
|
|
2021
Q4 | $4.74M | Buy |
136,312
+674
| +0.5% | +$21.4K | ﹤0.01% | 2375 |
|
|
2021
Q3 | $3.68M | Sell |
135,638
-7,189
| -5% | -$182K | ﹤0.01% | 2517 |
|
|
2021
Q2 | $3.7M | Buy |
142,827
+7,095
| +5% | +$170K | ﹤0.01% | 2492 |
|
|
2021
Q1 | $2.93M | Sell |
135,732
-6,657
| -5% | -$168K | ﹤0.01% | 2541 |
|
|
2020
Q4 | $3.06M | Buy |
142,389
+1,056
| +0.7% | +$25.6K | ﹤0.01% | 2455 |
|
|
2020
Q3 | $2.08M | Sell |
141,333
-14,139
| -9% | -$255K | ﹤0.01% | 2482 |
|
|
2020
Q2 | $3.47M | Buy |
155,472
+3,111
| +2% | +$56.9K | ﹤0.01% | 2198 |
|
|
2020
Q1 | $2.15M | Buy |
152,361
+3,176
| +2% | +$48.2K | ﹤0.01% | 2247 |
|
|
2019
Q4 | $2.42M | Buy |
149,185
+2,617
| +2% | +$61.9K | ﹤0.01% | 2361 |
|
|
2019
Q3 | $5.13M | Buy |
146,568
+7,412
| +5% | +$353K | ﹤0.01% | 1942 |
|
|
2019
Q2 | $7.85M | Buy |
139,156
+11,108
| +9% | +$800K | ﹤0.01% | 1743 |
|
|
2019
Q1 | $9.35M | Buy |
128,048
+4,788
| +4% | +$331K | 0.01% | 1642 |
|
|
2018
Q4 | $7.86M | Buy |
123,260
+13,272
| +12% | +$987K | 0.01% | 1619 |
|
|
2018
Q3 | $11M | Buy |
109,988
+25,646
| +30% | +$2.13M | 0.01% | 1574 |
|
|
2018
Q2 | $5.99M | Buy |
84,342
+5,067
| +6% | +$425K | ﹤0.01% | 1910 |
|
|
2018
Q1 | $8.25M | Buy |
79,275
+4,335
| +6% | +$489K | 0.01% | 1636 |
|
|
2017
Q4 | $7.55M | Buy |
74,940
+42,094
| +128% | +$3.1M | 0.01% | 1666 |
|
|
2017
Q3 | $1.15M | Buy |
32,846
+13,444
| +69% | +$363K | ﹤0.01% | 2469 |
|
|
2017
Q2 | $465K | Buy |
19,402
+9,414
| +94% | +$237K | ﹤0.01% | 2719 |
|
|
2017
Q1 | $278K | Buy |
+9,988
| New | +$233K | ﹤0.01% | 2842 |
|
Other funds holding ANAB
EC
TCM
AAA
VCM
PAI
6CM
